In children with asthma, do inhaled steroids reduce linear growth (height)?

Epling, John
July 2000
Journal of Family Practice;Jul2000, Vol. 49 Issue 7, p657
Academic Journal
This article presents a meta-analysis reviewing several studies which investigated whether inhaled steroids is capable of reducing linear growth in children with asthma. The research observed a reduce in growth velocity with chronic administration of inhaled beclomethasone in children with asthma. In this regard, the authors suggest that clinicians need to counsel families regarding the beneficial effects of inhaled steroids on controlling astham as well as their potential negative consequences on growth. INSET: Recommendations for clinical practice..


Related Articles

  • A Comparison of Beclomethasone, Salmeterol, and Placebo in Children with Asthma. Simons, F. Estelle R. // New England Journal of Medicine;12/04/97, Vol. 337 Issue 23, p1659 

    Background: An inhaled glucocorticoid is currently the medication of choice for long-term control of persistent asthma in children. The role of long-acting β2-adrenergic–receptor agonists, such as salmeterol, needs to be defined. Methods: We conducted a randomized, double-blind,...

  • Beclomethasone vs. theophylline for asthma.  // American Family Physician;1/1/1994, Vol. 49 Issue 1, p213 

    Compares the effectiveness of aerosol beclomethasone and sustained release oral theophylline in the treatment of asthmatic children as reported by Tinkelman and associates in the July 1993 issue of `Pediatrics.' Side effects; Reliance on supplemental medication; Growth velocity suppression.

  • The Value of Comparative Effectiveness Research in Asthma Management. Wilcox, David E. // Journal of Managed Care Medicine;2011, Vol. 14 Issue 1, p35 

    As the prevalence of chronic conditions continues to rise in the United States, healthcare decision makers are evaluating strategies to provide quality, cost-effective care. Although relatively new in the United States, comparative effectiveness research (CER) has moved to the forefront of U.S....

  • Choosing Therapy for Childhood Asthma. Holgate, Stephen T.; Frew, Anthony J. // New England Journal of Medicine;12/04/97, Vol. 337 Issue 23, p1690 

    Editorial. Focuses on choosing a therapy for childhood asthma. The availability of inhaled corticosteroids, cromolyn sodium or nedocromil sodium, beclomethasone dipropionate and salmeterol; Other options, such as environmental interventions; Reference to work by Simons et al in same issue.

  • Oral beclomethasone dipropionate as an alternative to systemic steroids in mild to moderate ulcerative colitis not responding to aminosalicylates. Papi, Claudio; Aratari, Annalisa; Moretti, Alessandra; Mangone, Manuela; Margagnoni, Giovanna; Koch, Maurizio; Capurso, Lucio // Digestive Diseases & Sciences;Jul2010, Vol. 55 Issue 7, p2002 

    Background: Aminosalicylates (5-ASA) are first-line treatment for mild-moderate ulcerative colitis (UC). Systemic corticosteroids (CS) are considered for patients in whom 5-ASA has been unsuccessful, but their use is limited by adverse effects. Beclomethasone dipropionate (BDP), a...

  • Efficacy and Safety of Oral Beclomethasone Dipropionate in Ulcerative Colitis: A Systematic Review and Meta-Analysis. Manguso, Francesco; Bennato, Raffaele; Lombardi, Giovanni; Riccio, Elisabetta; Costantino, Giuseppe; Fries, Walter // PLoS ONE;11/15/2016, Vol. 11 Issue 11, p1 

    Background and Aim: We performed a systematic review and meta-analysis of all the available evidence comparing efficacy and safety of oral prolonged released beclomethasone dipropionate (BDP) to active oral controls in patients with mild-to-moderate ulcerative colitis (UC). A subgroup-analysis...

  • Bioequivalence of Press-and-Breathe and Breath-Actuated Inhalers of Beclomethasone Dipropionate Extrafine Aerosol. Soria, I.; Harrison, L.; Myhre, P.; Pierce, A.; Machacek, J.; Ekholm, B.; Wang, Z.; Cline, A.; Helget, A. // Clinical Drug Investigation;2002, Vol. 22 Issue 8, p523 

    Objective: To assess the bioequivalence of beclomethasone dipropionate (BDP) delivered from a press-and-breathe (PB) inhaler and a breath-actuated inhaler (Autohalerâ„¢, AH). Design: Two randomised, open-label, single-dose, four-period crossover studies. Patients: Patients with mild asthma...

  • Intranasal beclomethasone: wonder drug or hazard?  // British Medical Journal;12/25/1976, Vol. 2 Issue 6051, p1522 

    Focuses on the use of beclomethasone dipropionate aerosols in treating rhinitis. Increase in enzymatic degradation in vivo; Optimum dosage of the agent; Use as a powerful and safe weapon in the symptomatic treatment of allergic and vasomotor inflammation.

  • Efficacy and Tolerability of a New Non-Extrafine Formulation of Beclomethasone HFA-134a in Patients with Asthma: Comparison with Beclomethasone CFC. Rocca-Serra, J.P.; Vicaut, E.; Lefrancois, G.; Umile, A. // Clinical Drug Investigation;2002, Vol. 22 Issue 10, p653 

    Objective: The aim of this study was to demonstrate that a new non-extrafine metered-dose inhaler formulation of beclomethasone (beclomethasone dipropionate) containing hydrofluoroalkane (HFA) propellant is no less effective or well tolerated than a formulation containing chlorofluorocarbon...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics